NSE IPO DRHP Filed: Latest GMP, Issue Size, Retail Quota & Updates

The National Stock Exchange of India Limited filed its Draft Red Herring Prospectus (DRHP) with SEBI and BSE on June 17, 2026. The filing marks the formal start of the regulatory review process for what is expected to be one of the largest IPOs in Indian market history.
📲 Get allotment alerts the moment results go live. Join the IPOwiz Telegram channel for real-time updates.
📋 Table of Contents
NSE IPO Key Details Table
| Parameter | Details |
|---|---|
| Issue Type | 100% Offer for Sale (OFS) |
| Total Shares Offered | Up to 14,89,05,525 equity shares |
| Estimated Issue Size | Rs. 25,000 crore to Rs. 30,000 crore |
| Indicative Valuation | Rs. 5 lakh crore+ (approx. $60 billion) |
| Face Value | To be confirmed in RHP |
| Retail Quota | Up to 10% of net offer |
| QIB Quota | Not less than 75% of net offer |
| NII / HNI Quota | Not more than 15% of net offer |
| Listing Exchange | BSE (Mainboard) only |
| Registrar | KFin Technologies Limited |
| Price Band | To be announced post-SEBI review |
| Subscription Dates | To be announced |
| Bombay High Court Petition | Pending, seeking stay on listing |
NSE IPO GMP Today: Unlisted Share Price and Market Trend
Because the DRHP was filed on June 17, 2026, and SEBI review is pending, there is no formal grey market premium (GMP) active for the NSE IPO at this stage.
However, the unlisted share market has been tracking NSE shares for several years. Recent private market transactions show NSE unlisted shares changing hands in the range of Rs. 1,950 to Rs. 2,050 per share.
What this unlisted price implies:
- At Rs. 2,000 per share and an indicative valuation of Rs. 5 lakh crore, the implied total share count is approximately 250 crore shares.
- This unlisted price corridor will serve as the baseline reference once the formal price band is announced.
- A formal GMP will develop on IPO trackers once SEBI issues its observations letter and the price band is confirmed.
For live updates on NSE unlisted share price movements and GMP once it activates, you can track real-time data on the IPOwiz GMP tracker or join the IPOwiz Telegram channel for instant alerts.
Why NSE Will List on BSE Instead of Its Own Exchange
This is one of the most commonly asked questions about the NSE IPO, and the answer is straightforward.
SEBI regulations bar an exchange operator from listing its own shares on its own platform. The conflict of interest is obvious: NSE cannot regulate and trade its own stock simultaneously.
As a result, NSE shares will list and trade exclusively on the BSE mainboard. This mirrors the arrangement for BSE Limited, whose shares currently trade on NSE.
This cross-listing structure creates an interesting dynamic where both exchanges will be listed on each other's platforms, making them simultaneously competitors and hosts for each other's equity.
NSE IPO Structure: Why the Issue Is 100% OFS
The NSE IPO is a 100% Offer for Sale. The company will receive no proceeds from this issue. Every rupee raised will go to the selling shareholders, which include:
- State Bank of India: Offloading 2,47,50,000 shares
- MS Strategic Mauritius: Selling 1,60,00,000 shares
- Various domestic banks, insurance companies, and early institutional investors
What this means for investors: The OFS structure is neither positive nor negative on its own. NSE already operates with zero external debt and strong internal cash generation. It does not need fresh capital. The listing is primarily about providing price discovery, liquidity, and public ownership of a systemically important institution.
However, investors should note that in an OFS, the money you pay goes to existing shareholders exiting their positions, not into building the business further.
NSE's Market Dominance: The Numbers Behind India's Largest Exchange
NSE's competitive position across Indian financial markets is exceptional. The data from the DRHP shows near-total dominance in most segments:
| Segment | NSE Market Share |
|---|---|
| Cash Equity (by turnover) | 92.99% |
| Equity Futures | 99.79% |
| Equity Options (by volume) | 74.71% |
| Currency Futures | 99.48% |
| Currency Options | 100.00% |
Global Positioning Metrics:
- Rank 1 globally in equity derivatives contracts traded (51.18% global market share)
- Rank 3 globally in total cash equity trades (11.38% global market share)
This level of market concentration creates a powerful network effect. Liquidity attracts more participants, which deepens liquidity further. Competing exchanges face an extremely high barrier to dislodge NSE from these positions.
Inside NSE's Technology Infrastructure and Processing Capacity
NSE's technology platform is built to handle extreme transaction loads:
- Active trading terminals: 200,000+ across 1,400+ cities
- Geographic reach: 99%+ of India's PIN codes
- Peak processing capacity: 21.89 billion order messages per day
- Throughput speed: Over 5 million messages per second
- Latency: Nanosecond-level execution for algorithmic trading desks
This infrastructure is a genuine competitive moat. Replicating it at this scale and reliability level would require years of capital investment and operational experience that no new entrant can easily replicate.
NSE FY26 Financials: Revenue, Profit and Key Metrics
NSE's financial performance for FY26 (year ending March 31, 2026) shows a highly profitable, capital-light business:
| Metric | FY26 Results |
|---|---|
| Revenue CAGR (FY22-FY26) | 20.51% |
| Profit After Tax (PAT) | Rs. 10,302 crore |
| PAT Margin | 55.05% |
| Return on Equity (ROE) | 32.98% |
Important note on FY26 earnings: The FY26 PAT includes a one-time pre-tax exceptional gain of Rs. 1,200.94 crore from the partial sale of NSE's stake in NSDL. Investors should adjust for this when calculating a normalized earnings base for valuation purposes.
Even after removing this exceptional item, the underlying business generates industry-leading margins. For context, Nasdaq operates at approximately a 21.53% net margin. NSE's 55% margin reflects its near-monopoly position and low incremental cost structure.
NSE IPO Valuation: How Does It Compare with BSE?
The price band has not been announced. However, based on the indicative valuation range of Rs. 5 lakh crore, here is how NSE compares to its only listed Indian peer, BSE Limited:
| Metric | NSE (Indicative) | BSE Ltd (Listed) |
|---|---|---|
| Market Cap | Rs. 5 lakh crore+ | Approx. Rs. 75,000 crore |
| PAT (FY26) | Rs. 10,302 crore | To be compared |
| PAT Margin | 55.05% | Lower |
| P/E Multiplier | Approx. 48-50x (normalized) | Lower multiple |
| Market Share (Derivatives) | Dominant | Minimal |
NSE commands a significant premium to BSE on fundamentals, given its monopoly in derivatives and far larger revenue base. However, at a Rs. 5 lakh crore valuation, the implied P/E of approximately 48 to 50 times normalized earnings is not cheap.
Investors should wait for the official price band before making a final subscription decision. The valuation at listing will determine whether the premium is justified or stretched. A formal valuation analysis will be published on this page once the price band is officially announced.
NSE Subsidiaries: The Ecosystem Beyond the Stock Exchange
NSE's value extends beyond its matching engine. The group operates through several wholly owned subsidiaries:
- NSE Clearing Limited: Manages clearing, settlement, and counterparty risk guarantee for all trades executed on the exchange.
- NSE Indices Limited: Owns and licenses the Nifty family of indices. Every mutual fund, ETF, or structured product that tracks Nifty 50 or any Nifty index pays a recurring licensing fee to this entity. This is a high-margin, recurring revenue stream that grows automatically as AUM in index-linked products increases.
- NSE Data and Analytics Limited: Packages and licenses live data feeds, historical order books, and transaction analytics to global financial platforms, terminal vendors, and research firms.
- NSE Infotech Services Limited: Manages core IT infrastructure, cybersecurity, and data center operations.
- NSE International Exchange (NSEIX) at GIFT City: Holds 99.81% market share in equity derivatives within the GIFT City IFSC. Also operates NSEIX Global Access, launched in February 2026, which allows Indian retail investors to trade US and international stocks through a single compliant gateway.
Bombay High Court Petition: A Key Issue Investors Should Track
The NSE DRHP discloses a pending petition before the Bombay High Court. This is a material risk that investors must understand before applying.
⚖️ Core Demands in the Active Petition:
- A judicial investigation into the foreign shareholding configurations and ultimate beneficial ownership structures of specific early investors in NSE.
- A formal stay on the entire listing process until the ownership investigation is completed.
Current Status & Historical Context: The petition is pending. No stay has been granted as of the DRHP filing date. NSE has resolved several previous SEBI enforcement actions, including the long-running co-location facility dispute. However, the Bombay High Court petition is a separate matter and introduces genuine regulatory uncertainty.
What investors should watch: Any court order granting a stay would delay the subscription timeline. Investors should monitor court hearing updates before committing capital. The DRHP itself flags this as a risk factor.
NSE IPO Retail Quota Explained: Why is it only 10%
Unlike most mainboard IPOs where retail investors receive 35% of the net offer, the NSE IPO allocates only 10% to retail individual investors. This is because the IPO is a 100% OFS with no fresh issue component. Under SEBI regulations, the retail quota for OFS-only issues follows a different allocation framework.
What this means practically: With a Rs. 30,000 crore issue and only 10% allocated to retail, approximately Rs. 3,000 crore is available for retail bidders. Given the brand recognition and expected demand, oversubscription in the retail category could be very high, making allotment competitive and largely lottery-dependent.
Projected lot size (indicative, not confirmed): Based on mainboard guidelines and the unlisted price corridor of Rs. 1,950 to Rs. 2,050, the minimum retail lot is expected to fall within a Rs. 14,000 to Rs. 15,000 range. This will be confirmed in the final RHP.
How to Improve Your Allotment Chances in the NSE IPO
Given the tight 10% retail quota and expected high oversubscription, allotment will be competitive. Practical steps to improve allotment probability include:
Checking allotment status: The registrar for this IPO is KFin Technologies Limited. Allotment status can be checked on the KFintech website, BSE, or NSE once the basis of allotment is published. To check allotment status across multiple family accounts simultaneously without manual refreshing, the IPOwiz app allows bulk PAN tracking from a single screen.
NSE IPO Risks: What Investors Should Know
⚠️ 1. Volatility & Volume Dependency
A significant portion of NSE's revenue comes from transaction fees. An extended bearish market cycle or a sharp decline in retail trading activity would directly compress revenue. The derivatives boom of recent years has been a major earnings driver. Any regulatory action capping F&O activity would have an outsized impact.
⚠️ 2. Regulatory Adjustments Risk
SEBI has historically intervened in exchange fee structures and market microstructure. Any future changes to derivatives transaction charges, lot sizes, or expiry structures could affect NSE's revenue model materially.
⚠️ 3. Bombay High Court Litigation
As detailed above, the pending petition seeking a listing stay is a genuine risk to the IPO timeline and baseline calendar projections.
⚠️ 4. Demutualized Structure Layout (No Core Promoter)
NSE operates with a demutualized structure and no identifiable single promoter. Governance is managed through public interest directors. While this is structurally sound, it can create alignment gaps during major strategic decisions.
⚠️ 5. Valuation Premium Risk
At an indicative Rs. 5 lakh crore valuation, the implied P/E on normalized earnings is approximately 48 to 50 times. This is not inexpensive for an exchange business, even one with monopoly characteristics. Investors expecting large listing gains may be disappointed if the price band is set aggressively.
⚠️ 6. OFS Supply Overhang Post-Listing
Selling shareholders include large institutional investors. Their exit through this IPO reduces their holdings, but remaining institutional shareholders may continue to sell in the secondary market post-listing, creating potential supply pressure.
NSE IPO Review: Should You Apply or Avoid?
NSE is a genuinely exceptional business. The combination of near-monopoly market share in derivatives, a 55% net profit margin, 32.98% ROE, and a technology infrastructure that processes 21 billion order messages daily is difficult to find anywhere in the Indian listed universe.
The business model is essentially a toll booth on Indian financial markets. As the economy grows, more investors participate, more trades are executed, and NSE collects more fees. This structural compounding is a legitimate long-term investment thesis.
However, there are important caveats before applying:
- The price band has not been announced. Valuation at listing will determine whether this is attractively priced or stretched.
- The Bombay High Court petition is a genuine risk to the timeline and should be monitored.
- The 10% retail quota means allotment will be highly competitive.
- The OFS structure means no capital goes to the company. You are buying shares from existing sellers, not funding growth.
Our view: NSE is a high-quality business worth owning for the long term. Whether the IPO itself offers good value depends entirely on the price band. Investors should wait for the official price band announcement before making a final decision. A subscription recommendation without a price band is not useful to investors. This page will be updated with a specific recommendation once the price band is confirmed.
NSE IPO Timeline: What Happens Before the Listing?
| Event | Status / Expected Timeline |
|---|---|
| DRHP Filed with SEBI | June 17, 2026 (Completed) |
| SEBI Review Period | 30 to 75 days from filing |
| SEBI Observations Letter | Expected August to September 2026 |
| Price Band Announcement | After SEBI clearance |
| Subscription Window | Likely Q3 or Q4 2026 |
| Allotment Tracking Schedule | Approximately T+6 from subscription close |
| Listing on BSE | To be announced |
| Bombay High Court Hearing | Ongoing, monitor closely for updates |
Frequently Asked Questions
Has the NSE IPO subscription date been announced?
No. The DRHP was filed on June 17, 2026. Subscription dates will be announced only after SEBI completes its review and issues its observations letter, which typically takes 30 to 75 days.
Will NSE shares trade on NSE?
No. SEBI regulations prevent an exchange from listing its own shares on its own platform. NSE shares will list and trade exclusively on the BSE mainboard.
Is the NSE IPO a fresh issue or OFS?
It is a 100% Offer for Sale of up to 14,89,05,525 equity shares. The company receives no proceeds. All funds go to the selling shareholders.
What is the NSE IPO GMP today?
There is no active formal GMP at this stage as the price band has not been announced. NSE unlisted shares have been trading in the Rs. 1,950 to Rs. 2,050 range in private markets. A formal GMP will develop once the price band is confirmed.
Who is the registrar for the NSE IPO?
KFin Technologies Limited is the designated registrar. Allotment status will be available on the KFintech website, BSE, and NSE post-allotment.
What is the retail quota for the NSE IPO?
Up to 10% of the net offer is reserved for retail individual investors. This is lower than the standard 35% because the issue is a 100% OFS.
Is there a legal risk with the NSE IPO?
Yes. A petition is pending before the Bombay High Court seeking an investigation into foreign shareholding structures and a stay on the listing process. No stay has been granted as of the DRHP filing date. Investors should monitor this.
Who are the book running lead managers for the NSE IPO?
The BRLMs have not been confirmed in publicly available reports at the time of publishing. This article will be updated when official BRLM details are disclosed.